Answers are grounded in this paper and cite their sources.
Cohort study investigates maternal ultra-processed food intake impact on pediatric IBD risk, suggesting no direct link.
Background Maternal intake of ultra-processed foods (UPFs), defined as food formulations made from a series of industrial processes, during pregnancy has been linked to several adverse health outcomes in both mothers and offspring. Yet, the impact on the risk of inflammatory bowel disease (IBD) in offspring remains poorly understood. Therefore, we investigated this within mother-child pairs from the Danish National Birth Cohort. Methods The Danish National Birth Cohort is a nationwide prospective cohort of Danish pregnant mothers and their offspring, enrolled in early pregnancy (1996–2002). In gestational week 25, a semi-quantitative food frequency questionnaire assessed maternal intake of 360 food items during the previous month. Foods were categorized according to the Nova classification system based on their level of industrial processing: 1) unprocessed or minimally processed foods, 2) processed culinary ingredients, 3) processed foods, and 4) UPFs. UPFs were further divided into seven subgroups (dairy, meat products, dressings & margarine, sweets & cakes, sugar-sweetened beverages, artificially sweetened beverages, and liquor). Children diagnosed with IBD (≤18 years), including Crohn’s disease (CD) and ulcerative colitis (UC), were identified in national health registers through their civil registration number. Cox regression estimated hazard ratio (HR) and 95% confidence interval (CI) for pediatric-onset IBD development in offspring according to tertiles of maternal UPF intake, with the lowest tertile as reference. Models were adjusted for maternal education, pre-pregnancy body mass index, smoking, supplements, and antibiotics during pregnancy, and parental IBD. Results Among 59,483 mother-child pairs, 170 (0.3%) offspring developed pediatric-onset IBD (CD: 94, UC: 76). Maternal UPF intake contributed a median of 20% (Interquartile range: 15.6–25.1%) of total energy intake, ranging from 13.9% to 27.6% in the lowest versus highest tertile. Mothers with higher UPF intake had worse diet quality scores with higher intake of saturated fat and sugar and lower intake of fiber and protein. Despite this, higher maternal UPF intake was not associated with increased IBD risk in offspring (HR: 1.15; 95% CI: 0.76–1.75), nor with risk of CD (HR: 1.07; 95% CI: 0.65–1.74) or UC (HR: 1.44; 95% CI: 0.84–2.47) individually. Furthermore, UPF subtypes were also not associated with offspring’s disease risk. Conclusion In this large-scale cohort study from Denmark, maternal UPF intake during pregnancy was not associated with risk of pediatric-onset IBD in offspring. However, the unfavorable nutrient profile among mothers with high UPF intake highlights that UPFs may still adversely affect offspring health through other mechanisms. Conflict of interest: Anneberg, Olivia Mariella Rosie: No conflict of interest Ciobotaru, Gabriela: No conflict of interest Vinkel Hansen, Anne: No conflict of interest Olsen, Sjurdur Frodi: No conflict of interest Bjerregaard, Anne Ahrendt: No conflict of interest Halldorsson, Thorhallur: No conflict of interest Guedelha Sabino, João: Speaker’s fees: Lilly, Pfizer, Abbvie, Ferring, Falk, Takeda, Janssen, Fresenius, and Galapagos. Consultancy fees: Takeda, Pfizer, Janssen, Ferring, Fresenius, Abbvie, Galapagos, Celltrion, Pharmacosmos, and Pharmanovia. Research support: Galapagos, Viatris, and Eurogenerics. JS is supported by a Senior Clinical researcher grant from the Research foundation – Flanders. Jess, Tine: Personal Fees: Consultancy for Ferring, Pfizer, Johnson & Johnson Brusco De Freitas, Maiara: No conflict of interest
No takes yet. Share an insight, caveat, or question.
Anneberg et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: